Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010

NCT00175019 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1086

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Febuxostat
DRUG: Febuxostat
DRUG: Allopurinol

Sponsor

Takeda